The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Dorsey, R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Dorsey, R.

Am J Psychiatry 1978; 135:1049-1058
Copyright © 1978 by American Psychiatric Association


REGULAR ARTICLES

The American Psychiatric Association and the Food and Drug Administration: an analysis and proposal for action

R Dorsey

The relationship between medicine and society is currently undergoing substantial change. While the Food and Drug Administration has no legal authority over the practicing physician, its decisions already influence medical practice. The Drug Regulation Reform Act of 1978, if passed in its present form, would grant FDA broad new powers over patient care and clinical research. In order to retain a high degree of control of its future and activities, the American Psychiatric Association must develop an effective mechanism for meeting this challenge and for serving the interests of its members and their patients. Dr. Alexander M. Schmidt comments on the author's presentation.





Get information about faster international access.

Privacy Policy

Copyright © 1978 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org